Audrey Clarissa: Making A Difference Through A 360-Degree Approach
By: Audrey Clarissa, Managing Director, PT. Imedco Djaja
Edwin Tjahyadi, President Director, PT Quantum Laboratoris Internasional
In the fast-paced and ever-evolving pharmaceutical and life sciences sectors across Asia, strong leadership plays a crucial role in driving innovation, ensuring compliance, and fostering sustainable growth in an increasingly complex and competitive environment. Leaders in this region face a unique array of challenges, ranging from navigating shifting regulatory landscapes to managing diverse teams and operations spread across multiple countries. The ability to adapt to these dynamic changes, coupled with the capacity to implement strategic solutions, has a significant and lasting impact on the long-term success of their organizations.
Audrey Clarissa: Making A Difference Through A 360-Degree Approach
By: Audrey Clarissa, Managing Director, PT. Imedco Djaja
New Challenges for Asia's Pharmaceutical Realm
By: Sujith Vasudevan, Managing Editor
US President Donald Trump has announced that the country is set to impose an additional 25 percent tariffs on automobile, semiconductor and pharmaceutical imports from April 2.
Transparency and Competency: Key to Harmonizing Innovation and Oversight in GenAI
By: Bryan Kirschner, Vice President Strategy, DataStax
Generative AI (GenAI) is transforming industries at an unprecedented pace, offering new avenues for innovation while raising critical questions about governance.
By: Sriraman Raghunathan, Head & Chief Architect, Marlabs
This requires a multipronged approach that combines broader strategic vision, organizational leadership commitment and support.
By: Nuseir Yassin, Founder & CEO, Nas Company
When building a technology company, the hardest thing is probably not coding; it is hiring talent. Hiring is expensive, especially if you hire talented people in America or Silicon Valley, since it will cost you half a million dollars.
By: Dr. Sung Ho Wang, CEO, Nemesis
The global semiconductor industry is traveling along an envious growth trajectory, driven by almost every technology product around us—from anything as tiny as earbuds to as big as an aircraft.
By: Dr. Anuj Kacker, Chief Executive Officer (Interim), Aptech
Let’s uncover the problems behind this industry academia gap through the lens of a veteran who has been around the game for 37 years - 20 years in the education and training industry alone.
Top 10 Leaders In Pharma & Life Sciences From Asia - 2025
The pharmaceutical and life sciences industry of Asia is set to witness astounding growth over the next few years, with increasing R&D investments and government initiatives fostering more advancements in healthcare. The variety of regulations across the Asian markets brings with it the need for companies to navigate many approval processes and compliance standards. Intellectual property remains a persistent issue, especially in emerging markets where enforcement is spotty at best. On top of this, there is pressure on companies to optimize costs while being innovative in the development of high-quality pharmaceuticals. Disruption of supplies, as was evident during the COVID-19 pandemic, showed that production and distribution networks often lack resilience.
Going forward into the future, Asia is looking to be transformed in the pharmaceutical and life sciences arena by advances in technology and pushing patient and healthcare demands. AI-enabled drug discovery, personalized medicine, and biotech innovations like mRNA technology and cell therapies are just taking off. The Asia region is also blooming with digital health solutions, moving telemedicine and wearable technology into cases that will revolutionize patient care. In turn, strategic alliances among global and local players would further propel Asia's assertiveness in pharmaceuticals and life sciences.
Companies with innovation, regulatory flexibility, and sustainability will take the lead in the race ahead. Asia has great potential to shape the future of global healthcare-making it as a region that one cannot afford to ignore in the next upcoming decades.
CEO Insights Asia in this issue presents a list of ‘Top 10 Leaders from Pharma and Life Sciences from Asia - 2025' who have leveraged their extensive industry expertise and experience in offering effective skills to the market. The following list has been prepared after being closely scrutinized by a distinguished panel of judges including CXOs, analysts and our editorial board. We recognize their valuable contribution to the ever expanding and competitive market and their ability to sustain themselves and emerge as top contestants through their reliable knowledge.
Company Logo | Company Management | Company Name | Company Description |
---|---|---|---|
![]() |
Audrey Clarissa, Managing Director | Imedco Djaja | With a track record of leadership, she has made contributions to various organizations across local, national, regional, and global levels, driving innovation, collaboration, and positive change in the healthcare and pharmaceutical sectors |
![]() |
Christophe Weber, President & CEO | Takeda Pharmaceutical Company | With more than 15 years of experience in pharma industry, he focuses on globalization and driving an R&D transformation while creating a diverse and inclusive working environment of the company |
![]() |
Edwin Tjahyadi, President Director | Quantum Laboratoris Internasional | With a background in both operations and finance, his career began in supportive roles, where he honed his skills in evaluating potential risks and opportunities in business partnerships and collaborations |
![]() |
Parag Swadia, CEO & Executive Director | Otsuka Pharmaceutical India | With over 25 years of experience in Finance, Corporate Affairs, Supply Chain, HR, and Business Strategy, he is driving innovation, quality, and growth in healthcare through his visionary leadership at the company |
![]() |
Rishikumar Nadarajah, Co-Founder & Managing Director | Celogen | He focuses on expanding the company into new markets, product categories, and obtaining regulatory certifications such as the US FDA and UK MHRA for our facilities |
![]() |
Robert Wonsang Yu, CEO | Yuyu Pharma | With over 20 years of experience in the pharmaceutical industry, he specializes in strategic leadership, global market expansion, and innovative drug development |
![]() |
Shakthi M Nagappan, CEO | Lifesciences and Pharma Telangana | With over 17 years of experience in the lifesciences and biotechnology industries, he focuses on attracting new companies to the region, supporting local companies in scaling globally and building partnerships |
![]() |
Sujeewa Goonetilleka, CEO | Laugfs Life Sciences | He oversees the company's operations in the pharmaceutical and life sciences sectors and has more than 25 years of experience in pharma industry |
![]() |
Suman M, CEO | OrciMed Life Sciences | With over 18 years of experience in the pharmaceutical and life sciences industry, he is passionate to provide innovative and affordable solutions for global health challenges |
![]() |
Sundeep Aurora, CEO | Bioplus Lifesciences | He focuses on the company's specialization in the development and manufacturing of pharmaceutical and nutraceutical products, with expertise in novel drug development and microbial fermentation |
Other Issues
We use cookies to ensure you get the best experience on our website. Read more...